Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now Mar 5, 2024 07:00AM
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024 Mar 1, 2024 08:30AM
Dow futures rise 70 pts; Fed's preferred inflation gauge due Dec 23, 2022 07:31AM
U.S. Stocks Open Lower as Growth-Charged Rally Fades Oct 5, 2022 09:57AM
GBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights May 10, 2022 04:05PM


May 10, 2022 04:05PM GBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights
Mar 31, 2022 04:05PM GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center
Mar 7, 2022 08:30AM GBS Inc. to Participate in the Upcoming March Investor Conferences
Feb 10, 2022 04:05PM GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
Feb 10, 2022 04:05PM GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
Dec 20, 2021 07:10AM GBS Inc. to Participate in the Upcoming January Virtual Investor Conferences
Dec 13, 2021 08:00AM GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
Nov 30, 2021 08:00AM GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study
Nov 11, 2021 04:05PM GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
Nov 11, 2021 04:05PM GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
Nov 1, 2021 08:12AM GBS Inc. (GBS) appoints Professor Steven Boyages, PhD, Chairman, to position of Interim Chief Executive Officer
Nov 1, 2021 08:00AM GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
Nov 1, 2021 08:00AM GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
Oct 13, 2021 08:30AM GBS Inc. (GBS) Files Pre-Submission with the FDA
Oct 13, 2021 08:30AM GBS Inc. Announces its Pre-Submission package is with the FDA
Oct 13, 2021 08:30AM GBS Inc. Announces its Pre-Submission package is with the FDA
Sep 7, 2021 04:05PM GBS Inc. to Present at Upcoming September Virtual Investor Conferences
Sep 7, 2021 04:05PM GBS Inc. to Present at Upcoming September Virtual Investor Conferences
Aug 11, 2021 04:05PM GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
Aug 11, 2021 04:05PM GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
Jul 29, 2021 08:30AM GBS Inc. to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on August 11
Jul 29, 2021 08:30AM GBS Inc. to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on August 11
Jul 26, 2021 08:00AM GBS Inc. Engages L.E.K. Consulting Hong Kong Pty Limited to Identify Potential Sublicensees in China for its Saliva-Glucose Diabetes Test
Jul 26, 2021 08:00AM GBS Inc. Engages L.E.K. Consulting Hong Kong Pty Limited to Identify Potential Sublicensees in China for its Saliva-Glucose Diabetes Test
Jul 8, 2021 09:22AM GBS Inc. (GBS) Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology
Jul 8, 2021 09:21AM GBS Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology
Jul 8, 2021 09:21AM GBS Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology
Jun 8, 2021 08:10AM Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey
Jun 8, 2021 08:10AM Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey